Previous studies using various cell lines, including glioma cell lines, have shown enhanced sensitivity of PTEN-deficient tumors to mTOR inhibition [30], which later was demonstrated to be due to Akt dependent regulation of Cyclin D1 and c-myc expression [31]. The gene discussed is AKT1; the disease is central nervous system cancer.